The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study
Abstract
To study the effects of androgen replacement therapy on muscle mass and strength and bone turnover markers in hypogonadal men, we administered sublingual testosterone (T) cyclodextrin (SLT; 5 mg, three times daily) to 67 hypogonadal men (baseline serum T, < 8.4 nmol/L) recruited from 4 centers in the U.S.: Torrance (n = 34), Durham (n = 12), New York (n = 9), and Salem (n = 12). Subjects who had received prior T therapy were withdrawn from injections for at least 6 weeks and from oral therapy for 4 weeks. Body composition, muscle strength, and serum and urinary bone turnover markers were measured before and after 6 months of SLT. We have shown previously that this regimen for 60 days will maintain adequate serum T levels and restore sexual function. Total body (P = 0.0104) and lean body mass (P = 0.007) increased with SLT treatment in the 34 subjects in whom body composition was assessed. There was no significant change in total body fat or percent fat. The increase in lean body mass was mainly in the legs; the right leg lean mass increased from 8.9 +/- 0.3 kg at 0 months to 9.2 +/- 0.3 kg at 6 months (P = 0.0008). This increase in leg lean mass was associated with increased leg muscle strength, assessed by leg press (0 months, 139.0 +/- 4.0 kg; 6 months, 147.7 +/- 4.2 kg; P = 0.0038). SLT replacement in hypogonadal men led to small, but significant, decreases in serum Ca (P = 0.0029) and the urinary calcium/creatinine ratio (P = 0.0066), which were associated with increases in serum PTH (P = 0.0001). At baseline, the urinary type I collagen-cross linked N-telopeptides/creatinine ratio [75.6 +/- 7.9 nmol bone collagen equivalents (BCE/mmol] was twice the normal adult male mean (41.0 +/- 3.6 nmol BCE/mmol) and was significantly decreased in response to SLT treatment at 6 months (68.2 +/- 7.7 nmol BCE/mmol; P = 0.0304) without significant changes in urinary creatinine. Serum skeletal alkaline phosphatase did not change. In addition, SLT replacement caused significant increases in serum osteocalcin (P = 0.0001) and type I procollagen (P = 0.0012). Bone mineral density did not change during the 6 months of SLT treatment. We conclude that SLT replacement therapy resulted in increases in lean muscle mass and muscle strength. Like estrogen replacement in hypogonadal postmenopausal females, androgen replacement therapy led to decreased bone resorption and urinary calcium excretion. Moreover, androgen replacement therapy may have the additional benefit of increasing bone formation. A longer term study for several years duration would be necessary to demonstrate whether these changes in bone turnover marker levels will result in increased bone mineral density decreased fracture risks, and reduced frailty in hypogonadal men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric and Distribution-Free Methods for the Social Sciences.
Bassler, J. F., Marascuilo, L. A., & McSweeney, M. (1978) · Journal of the American Statistical Association · doi:10.2307/2286625 · Cited by 978
Gallagher, J. C., Riggs, B. L., Eisman, J., Hamstra, A., Arnaud, S. B., & Deluca, H. F. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109516 · Cited by 861
Effects of testosterone supplementation in the aging male
Tenover, J. L. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400877 · Cited by 810
Hanson, D. A., Weis, M. A. E., Bollen, A.-M., Maslan, S. L., Singer, F. R., & Dr. Eyre, D. R. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071119 · Cited by 656
A General Methodology for the Analysis of Experiments with Repeated Measurement of Categorical Data
Koch, G. G., Landis, J. R., Freeman, J. L., Freeman, D. H., & Lehnen, R. G. (1977) · Biometrics · doi:10.2307/2529309 · Cited by 609
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
Urban, R. J., Bodenburg, Y. H., Gilkison, C., Foxworth, J., Coggan, A. R., Wolfe, R. R., & Ferrando, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e820 · Cited by 608
Effect of testosterone on muscle mass and muscle protein synthesis
Griggs, R. C., Kingston, W., Jozefowicz, R. F., Herr, B. E., Forbes, G., & Halliday, D. (1989) · Journal of Applied Physiology · doi:10.1152/jappl.1989.66.1.498 · Cited by 517
Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study
Morley, J. E., Perry, H. M., Kaiser, F. E., Kraenzle, D., Jensen, J., Houston, K., Mattammal, M., & Perry, H. M. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb02049.x · Cited by 463
Identification of androgen receptors in normal human osteoblast-like cells.
Colvard, D. S., Eriksen, E. F., Keeting, P. E., Wilson, E. M., Lubahn, D. B., French, F. S., Riggs, B. L., & Spelsberg, T. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.854 · Cited by 462
Journal of Bone and Mineral Research
Delmas, P. D. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081323 · Cited by 454
Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study
Wang, C. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3578 · Cited by 453
Self-citationOsteopenia in Men with a History of Delayed Puberty
Finkelstein, J. S., Neer, R. M., Biller, B. M. K., Crawford, J. D., & Klibanski, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260904 · Cited by 439
GALLAGHER, J. C., RIGGS, B. L., & DELUCA, H. F. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-6-1359 · Cited by 428
ŠTĚPÁN, J. J., LACHMAN, M., ZVĚŘINA, J., PACOVSKÝ, V., & BAYLINK, D. J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-523 · Cited by 424
Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism
FINKELSTEIN, J. S., KLIBANSKI, A., NEER, R. M., GREENSPAN, S. L., ROSENTHAL, D. I., & CROWLEY, W. F. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3- · Cited by 408
ANDROGENS DIRECTLY STIMULATE PROLIFERATION OF BONE CELLS IN VITRO
Kasperk, C. H., Wergedal, J. E., Farley, J. R., Linkhart, T. A., Turner, R. T., & Baylink (1989) · Endocrinology · doi:10.1210/endo-124-3-1576 · Cited by 399
Increases in Bone Density During Treatment of Men with Idiopathic Hypogonadotropic Hypogonadism*
FINKELSTEIN, J. S., KLIBANSKI, A., NEER, R. M., DOPPELT, S. H., ROSENTHAL, D. I., SEGRE, G. V., & CROWLEY, W. F. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-4-776 · Cited by 356
Behre, H. M., Bohmeyer, J., & Nieschlag, E. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03929.x · Cited by 335
Raisz, L. G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.37 · Cited by 278
Osteoporosis in Men with Hyperprolactinemic Hypogonadism
GREENSPAN, S. L., NEER, R. M., RIDGWAY, E. C., & KLIBANSKI, A. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-6-777 · Cited by 250
Importance of Gonadal Steroids to Bone Mass in Men with Hyperprolactinemic Hypogonadism
Greenspan, S. L., Oppenheim, D. S., & Klibanski, A. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-7-526 · Cited by 191
Studies of the Mechanism by which Androgens Enhance Mitogenesis and Differentiation in Bone Cells*
KASPERK, C., FITZSIMMONS, R., STRONG, D., MOHAN, S., JENNINGS, J., WERGEDAL, J., & BAYLINK, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-5-1322 · Cited by 168
Evidence for a Renal Calcium Leak in Postmenopausal Women
NORDIN, B. E. C., NEED, A. G., MORRIS, H. A., HOROWITZ, M., & ROBERTSON, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-401 · Cited by 167
Fukayama, S., & Tashjian, A. H. (1989) · Endocrinology · doi:10.1210/endo-125-4-1789 · Cited by 154
Benz, D., Haussler, M. R., Thomas, M. A., Speelman, B. A., & Komm, B. S. (1991) · Endocrinology · doi:10.1210/endo-128-6-2723 · Cited by 139
Androgen receptors in osteoblast-like cell lines
ORWOLL, E. S., Stribrska, L., Ramsey, E. E., & Keenan, E. J. (1991) · Calcified Tissue International · doi:10.1007/bf02556115 · Cited by 131
Corvol, M. T., Carrascosa, A., Tsagris, L., BLANCHARD, O., & Rappaport, R. (1987) · Endocrinology · doi:10.1210/endo-120-4-1422 · Cited by 126
Young, N., Baker, H. W. G., Liu, G., & Seeman, E. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.4.8408450 · Cited by 122
Salehian, B., Wang, C., Alexander, G. M., Davidson, T., McDonald, V., Berman, N., Dudley, R. E., Ziel, F. H., & Swerdloff, R. S. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530600 · Cited by 114
Self-citationWelle, S. L., Józefowicz, R. F., Forbes, G. B., & Griggs, R. C. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.2.1730811 · Cited by 113
Devogelaer, J. P., de Cooman, S., & de Deuxchaisnes, C. N. (1992) · Maturitas · doi:10.1016/0378-5122(92)90057-b · Cited by 111
Dr. Diamond, T., Stiel, D., & Posen, S. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060108 · Cited by 96
Androgen levels and sex functions in testosterone-treated hypogonadal men
Gooren, L. (1987) · Archives of Sexual Behavior · doi:10.1007/bf01541711 · Cited by 96
Carrascosa, A., Audí, L., Ferrández, M. A., & Ballabriga, A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-1-134 · Cited by 95
Kübler, A., Schulz, G., Cordes, U., et al. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211192 · Cited by 92
Testosterone and Bone Loss in Klinefelter Syndrome
Foresta, C., Ruzza, G., Mioni, R., Meneghello, A., & Baccichetti, C. (1983) · Hormone and Metabolic Research · doi:10.1055/s-2007-1018630 · Cited by 90
Pilbeam, C. C., & Raisz, L. G. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051114 · Cited by 77
Charles, P., Hasling, C., Risteli, L., Risteli, J., Mosekilde, L., & Eriksen, E. F. (1992) · Calcified Tissue International · doi:10.1007/bf00296671 · Cited by 55
Influence of testosterone and dihydrotestosterone on bone-matrix induced endochondral bone formation
Kapur, S. P., & Reddi, A. H. (1989) · Calcified Tissue International · doi:10.1007/bf02556469 · Cited by 50
Gregory, J. W., Greene, S. A., Thompson, J., Scrlmgeour, C. M., & Rennle, M. J. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02312.x · Cited by 49
Effect of menopause and aging on serum total and ionized calcium and protein concentrations
Sokoll, L. J., & Dawson‐Hughes, B. (1989) · Calcified Tissue International · doi:10.1007/bf02556562 · Cited by 48
Effect of testosterone on bone in hypogonadal males
Isaia, G., Mussetta, M., Pecchio, F., Sciolla, A., Stefano, M. D., & Molinatti, G. M. (1992) · Maturitas · doi:10.1016/0378-5122(92)90061-8 · Cited by 39
Two-site enzyme immunoassay for measuring intact human osteocalcin in serum
Parviainen, M. T., Kuronen, I., Kokko, H., Lakaniemi, M., Savolainen, K., & Mononen, I. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090309 · Cited by 36
Effect of Testosterone on Radial Bone Mineral Density in Adolescent Male Hypogonadism
Arisaka, O., Arisaka, M., Hosaka, A., Shimura, N., & Yabzrta, K. (1991) · Acta Paediatrica · doi:10.1111/j.1651-2227.1991.tb11866.x · Cited by 30
Cited by
Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656
Self-citationLong-term effect of testosterone therapy on bone mineral density in hypogonadal men
Behre, H. M., Kliesch, S., Leifke, E., Link, T. M., & Nieschlag, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4163 · Cited by 559
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Metadata
- Authors
- Wang, C.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1996-10-01
- Volume
- 81
- Issue
- 10
- Pages
- 3654-3662
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2139876233
- Cited by
- 261
- References
- 44
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.